|
Market Closed -
Bombay S.E.
03:32:26 04/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 72.56 INR | +1.48% |
|
-1.95% | +35.30% |
Company Valuation: Colinz Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 34.74 | 107.6 | 160 | 94.59 | 182.5 | 112.1 |
| Change | - | 209.87% | 48.62% | -40.87% | 92.92% | -38.57% |
| Enterprise Value (EV) 1 | -2.149 | 60.43 | 105.4 | 30.29 | 133.4 | 30.71 |
| Change | - | 2,911.96% | 74.47% | -71.27% | 340.39% | -76.98% |
| P/E | 16.7x | 31.8x | 19.2x | 19.5x | 36.8x | 21.8x |
| PBR | 0.48x | 1.4x | 1.08x | 1.06x | 1.93x | 1.12x |
| PEG | - | 0.5x | 0x | 3.23x | 17.76x | 6.14x |
| Capitalization / Revenue | 0.56x | 1.54x | 2.24x | 1.35x | 2.8x | 1.83x |
| EV / Revenue | -0.03x | 0.87x | 1.47x | 0.43x | 2.04x | 0.5x |
| EV / EBITDA | -0.65x | 10.3x | 16.7x | 5.58x | 26.9x | 7.54x |
| EV / EBIT | -1.52x | 15.7x | 20.9x | 7.34x | 36.7x | 12.2x |
| EV / FCF | -0.2x | 8.87x | 17.8x | 4.12x | -7.62x | 1.07x |
| FCF Yield | -506% | 11.3% | 5.62% | 24.3% | -13.1% | 93% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.4541 | 0.74 | 1.82 | 1.93 | 1.97 | 2.04 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 61.59 | 69.74 | 71.55 | 70.3 | 65.28 | 61.36 |
| EBITDA 1 | 3.331 | 5.862 | 6.326 | 5.428 | 4.951 | 4.075 |
| EBIT 1 | 1.418 | 3.85 | 5.037 | 4.125 | 3.639 | 2.512 |
| Net income 1 | 2.076 | 3.393 | 4.574 | 4.867 | 4.966 | 5.145 |
| Net Debt 1 | -36.89 | -47.22 | -54.55 | -64.3 | -49.09 | -81.39 |
| Reference price 2 | 7.60 | 23.55 | 35.00 | 37.55 | 72.44 | 44.50 |
| Nbr of stocks (in thousands) | 4,571 | 4,571 | 4,571 | 2,519 | 2,519 | 2,519 |
| Announcement Date | 30/08/21 | 24/08/22 | 29/08/23 | 29/08/24 | 28/08/25 | 20/08/26 |
1INR in Million2INR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 19.36L | ||
| 35.04x | 6.58x | 22.81x | 0.9% | 4.83TCr | ||
| 17.32x | 2.17x | 9.78x | 1.49% | 4.05TCr | ||
| 26.96x | 3.27x | 16.93x | 0.94% | 1.19TCr | ||
| 26.85x | 3.84x | 15.92x | 0.6% | 1.18TCr | ||
| 19.17x | 3.41x | 11.88x | 3.76% | 935.93Cr | ||
| 9.39x | 2.16x | 5.58x | 4.61% | 749.58Cr | ||
| 15.79x | 2.07x | 6.88x | 3.19% | 737.27Cr | ||
| 29.64x | 3.88x | 18.04x | 0.16% | 728.46Cr | ||
| Average | 22.52x | 3.42x | 13.48x | 1.96% | 1.6TCr | |
| Weighted average by Cap. | 25.09x | 4.04x | 15.43x | 1.51% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- COLINZ6 Stock
- Valuation Colinz Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















